When did Champions Oncology report Q3 2025 earnings?

Champions Oncology (CSBR) reported Q3 2025 earnings on September 15, 2025 after market close.

What were Champions Oncology's Q3 2025 revenue and EPS?

Champions Oncology reported revenue of $14.0M and diluted EPS of $-0.03 for Q3 2025.

Revenue missed the consensus estimate of $14.0M by $47.0K. EPS missed the consensus estimate of $0.01 by $0.04.

Compared to the same quarter a year prior, revenue declined 0.5% from $14.1M a year earlier.

You can read the 10-Q periodic report (0000771856-25-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported September 15, 2025 · After market close

Revenue estimate$14.0M

EPS estimate$0.01

Jul 16, 2026 (In 3 weeks)

Revenue estimate$12.9M

EPS estimate-$0.05

Q3 2025$14.0MMiss by $47.0K

Q3 2025-$0.03Miss by $0.04

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Champions Oncology report Q3 2025 earnings?: Champions Oncology (CSBR) reported Q3 2025 earnings on September 15, 2025 after market close.
What were Champions Oncology's Q3 2025 revenue and EPS?: Champions Oncology reported revenue of $14.0M and diluted EPS of $-0.03 for Q3 2025.
Did Champions Oncology beat estimates in Q3 2025?: Revenue missed the consensus estimate of $14.0M by $47.0K. EPS missed the consensus estimate of $0.01 by $0.04.
How did Champions Oncology's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 0.5% from $14.1M a year earlier.
Where can I find Champions Oncology's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0000771856-25-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.